BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Resonetics, LLC Appoints Medical Device Veteran as Chief Executive Officer


8/14/2012 7:50:41 AM

NASHUA, N.H., Aug. 13, 2012 /PRNewswire/ -- Resonetics, a leading supplier of polymer micromachining services and systems for the life sciences industry, announced that Tom Burns has been named Chief Executive Officer.

Burns brings 25 years of diverse experience in medical devices and contract manufacturing to the company. Most recently he was vice president of business development at Tegra Medical, where he led the strategy and customer facing operations for five acquired companies. Prior to Tegra, he served as vice president of sales and marketing for Web Industries, a contract manufacturer serving the medical diagnostics and aerospace industries. Burns spent nine years with Accellent and two of its acquired companies in various sales and marketing roles, providing contract engineering and manufacturing services to the medical device industry. In the first ten years of his career, Burns served in different sales, marketing and management roles for Genzyme, Edwards Lifesciences, and Johnson & Johnson. He has a B.S.B.A. from Northeastern University.

"We're pleased to have Tom lead the Resonetics team as we continue to hone our focus on the life sciences industry. His experience developing winning business solutions combined with his strong leadership skills and industry knowledge will be important as we continue to execute on our vision," said John Simons, chairman of the board, and partner at Corporate Fuel Partners, owner of Resonetics.

"I'm very excited about the opportunity at Resonetics. As medical devices and diagnostics continue to shrink and utilize novel materials, Resonetics' experience with polymer laser micromachining and automation offers OEMs a very flexible and cost-effective applications development and manufacturing solution to meet their most demanding design requirements," said Burns. "I am honored to join the talented group of individuals at Resonetics. I look forward to assisting in expanding the innovative capabilities, technology platform and know-how that is in place."

About Resonetics

Resonetics provides laser micromachining solutions and systems for medical device and diagnostic manufacturing and other applications requiring precision laser processing. Resonetics' expertise with polymers up to 1mm thick and with features as small as 1 micron is unmatched and offers the world's largest capacity for laser micromachining polymers in ultra-violet wavelengths. With more than 25 years of experience building systems and a dedicated development lab staffed with PhDs, optical scientists and automation experts, the company can address critical design requirements with a cost-effective and repeatable approach.

About Corporate Fuel Partners

Corporate Fuel Partners is a private equity affiliate of Corporate Fuel Advisors, a New York-based investment banking firm. The firm advises on mergers and acquisitions, and raising debt and equity capital. CFA concentrates on small to mid-size enterprises with revenue between $10 million and $200 million. The diverse experience of our partners and unique market focus allows us to bring an unmatched level of expertise to our clients.

SOURCE Resonetics



Read at BioSpace.com
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES